These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5555145)

  • 21. [Action of heparin, adrenaline and an adrenaline-heparin complex on thrombocyte aggregation and on plasma lytic activity in animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):28-33. PubMed ID: 4781491
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental investigations with proteinase inhibitors.
    Nordström S; Blombäck M; Olsson P; Zetterqvist E
    Acta Chir Scand Suppl; 1967; 378():33-40. PubMed ID: 5300105
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heparin and fibrinolysis inhibitors].
    Villaverde CA; Badimón L; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):97-100. PubMed ID: 7325724
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological study of some inhibitors of fibrinolysis].
    Gavrilov AP
    Farmakol Toksikol; 1967; 30(4):460-3. PubMed ID: 5598902
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of sodium heparin on activated fibrinolysis in the rat in vivo].
    Badimón L; Villaverde C; Badimón JJ; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):105-8. PubMed ID: 7325697
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of antifibrinolytic agents on thrombocyte aggregation in vitro and in vivo].
    Hladovec J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):524-8. PubMed ID: 4193170
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H; Niewiarowski S
    Thromb Diath Haemorrh; 1968 Jul; 19(3):584-92. PubMed ID: 4236825
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fibrinolytic inhibitors].
    Nagamatsu A
    Saishin Igaku; 1966 Feb; 21(2):320-5. PubMed ID: 5966316
    [No Abstract]   [Full Text] [Related]  

  • 31. [Method for the determination of the action of physiologic solvents of nonstabilized fibrin].
    Kudriashov BA; Liapina LA
    Lab Delo; 1971; 6():326-9. PubMed ID: 4108741
    [No Abstract]   [Full Text] [Related]  

  • 32. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"].
    Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA
    Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of an adrenaline-heparin complex on the blood in vivo].
    Liapina LA; Balakina TA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 5():38-42. PubMed ID: 4275517
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA].
    Fischer M
    Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160
    [No Abstract]   [Full Text] [Related]  

  • 36. [Complex compound of heparin and glutamic acid: synthesis and effect on hemostasis parameters in vitro and in vivo].
    Liapina LA; Ziadetdinova GA
    Izv Akad Nauk Ser Biol; 2001; (1):82-6. PubMed ID: 11236584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factor XIII activity in the presence of suppression of the function of the anticoagulant system and its restoration in animals on an atherogenic ration].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG; Sytina NP
    Vopr Pitan; 1976; (5):54-7. PubMed ID: 982947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental intravascular coagulation: impairment of renal blood flow following thrombin infusion in the dog.
    Hoie J; Schenk WG
    J Trauma; 1972 Apr; 12(4):302-8. PubMed ID: 5018411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.